Enzymes Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Enzymes Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032



Growth Factors of Enzymes Market

The enzymes market size was valued at USD 9 billion in 2019. The market is projected to grow from USD 8.9 billion in 2020 to USD 13.8 billion in 2027, exhibiting a CAGR of 6.4% during the forecast period of 2020-2027.

The COVID-19 pandemic adversely affected the enzymes marketplace due to disruptions in deliver chains, production halts, and decreased call for from key industries. Lockdowns and restrictions triggered delays in raw cloth availability and manufacturing operations, impacting enzyme production. The food and beverage sector, a widespread consumer of enzymes, experienced decreased operations and transferring client possibilities, further slowing market growth. Additionally, the textile and biofuel industries confronted decreased hobby, reducing enzyme demand. While the pharmaceutical sector noticed multiplied enzyme use for healthcare programs, it become inadequate to offset losses in different industries. Recovery started out as markets stabilized put up-pandemic, however challenges persist.

A massive fashion within the enzymes market is the developing adoption of enzymes in sustainable and green business methods. Industries are more and more using enzymes to update chemical catalysts, lowering electricity intake and environmental effect. For example, enzymes are being widely hired in biofuels manufacturing, biodegradable detergents, and eco-friendly food processing. Advances in enzyme engineering, including the improvement of thermostable and pH-resistant variants, are expanding their utility throughout various sectors. Additionally, the demand for enzymes in the pharmaceutical and private care industries is rising due to their efficiency in drug components and herbal product production, aligning with the global sustainability push.

One key driving thing in the enzymes marketplace is the developing call for bio-primarily based and sustainable solutions across numerous industries. As purchasers and agencies cognizance on reducing environmental impact, enzymes provide eco-friendly alternatives to traditional chemical approaches. In sectors including food and beverages, biofuels, textiles, and detergents, enzymes are more and more used to enhance efficiency, reduce energy intake, and minimize waste. Additionally, the rising focus of the fitness blessings of enzyme-based totally products in prescription drugs and personal care is boosting market growth. The shift in the direction of inexperienced chemistry and sustainability tasks is driving enzyme innovation and increasing its programs.

Comprehensive Analysis of Enzymes market

The Enzymes market growth is rising at an exponential rate due to its marketplace segmentation. This market expansion correctly affords a detailed local assessments thinking about the dominant supply and call for forces that effect the enterprise. These segmentations are methodically segregated by type include industrial enzymes and specialty enzymes, by source include plants, animals, and microorganisms, by product type include protease, lipase, carbohydrates, nuclease & polymerase, and others

The North America location lead the Enzymes market share percentage via benefitting a marketplace size of USD 3.5 billion due to the high investments by the rising number of clinical trials to develop potent therapeutics, especially in the U.S.

The top players in the market play a crucial role in the industry assuring market growth and setting market standards. These players include, Codeix, Sanofi, Advanced Enzymes, F. Hoffmann-La Roche Ltd, Codexis, Inc.,Advanced Enzyme Technologies, Other Prominent Players

December 2023: Aldevron and Codexis, Inc. Entered a worldwide licensing settlement for Codex HiCap RNA Polymerase to decorate the manufacturing of mRNA-based totally therapeutics. This collaboration objectives to enhance commercial penetration by means of enabling the green and scalable manufacture of mRNA therapeutics, supporting the growing call for RNA-based treatments international.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2016-2027

Base Year 2019

Forecast Period 2020-2027

Historical Period 2016-2018

Unit Value (USD Million)

Segmentation Type; Source; Product Type; and Region

By Type

Industrial Enzymes

Specialty Enzymes

By Source

Plants

Animals

Microorganisms

By Product Type

Protease

Lipase

Carbohydrates

Nuclease & Polymerase

Others

By Geography

North America

By Type

By Source

By Product Type

By Country

USA

Canada

Europe

By Type

By Source

By Product Type

By Country

UK

Germany

France

Italy

Spain

Scandinavia

Rest of Europe

Asia Pacific

By Type

By Source

By Product Type

By Country

Japan

China

India

Australia

Southeast Asia

Rest of Asia Pacific

Latin America

By Type

By Source

By Product Type

By Country

Brazil

Mexico

Rest of Latin America

Middle East & Africa

By Type

By Source

By Product Type

By Country

GCC

South Africa

Rest of MEA


1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Overview of Clinical Trials - Key Candidates, Key Companies
4.2. Regulatory Scenario
4.3. Impact of Covid-19 on the Market
4.4. Key Developments, Mergers, Acquisitions, etc.
4.5. New Product Launches
5. Global Enzymes Market Analysis, Insights and Forecast, 2016-2027
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Type
5.2.1. Industrial Enzymes
5.2.2. Specialty Enzymes
5.3. Market Analysis, Insights and Forecast – By Source
5.3.1. Plants
5.3.2. Animals
5.3.3. Microorganisms
5.4. Market Analysis, Insights and Forecast – By Product Type
5.4.1. Protease
5.4.2. Lipase
5.4.3. Carbohydrates
5.4.4. Nuclease & Polymerase
5.4.5. Others
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
6. North America Enzymes Market Analysis, Insights and Forecast, 2016-2027
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast - By Type
6.2.1. Industrial Enzymes
6.2.2. Specialty Enzymes
6.3. Market Analysis, Insights and Forecast - By Source
6.3.1. Plants
6.3.2. Animals
6.3.3. Microorganisms
6.4. Market Analysis, Insights and Forecast – By Product Type
6.4.1. Protease
6.4.2. Lipase
6.4.3. Carbohydrates
6.4.4. Nuclease & Polymerase
6.4.5. Others
6.5. Market Analysis, Insights and Forecast - By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe Enzymes Market Analysis, Insights and Forecast, 2016-2027
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast - By Type
7.2.1. Industrial Enzymes
7.2.2. Specialty Enzymes
7.3. Market Analysis, Insights and Forecast - By Source
7.3.1. Plants
7.3.2. Animals
7.3.3. Microorganisms
7.4. Market Analysis, Insights and Forecast – By Product Type
7.4.1. Protease
7.4.2. Lipase
7.4.3. Carbohydrates
7.4.4. Nuclease & Polymerase
7.4.5. Others
7.5. Market Analysis, Insights and Forecast - By Country/Sub Region
7.5.1. U.K.
7.5.2. Germany
7.5.3. France
7.5.4. Spain
7.5.5. Italy
7.5.6. Scandinavia
7.5.7. Rest of Europe
8. Asia Pacific Enzymes Market Analysis, Insights and Forecast, 2016-2027
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast - By Type
8.2.1. Industrial Enzymes
8.2.2. Specialty Enzymes
8.3. Market Analysis, Insights and Forecast - By Source
8.3.1. Plants
8.3.2. Animals
8.3.3. Microorganisms
8.4. Market Analysis, Insights and Forecast – By Product Type
8.4.1. Protease
8.4.2. Lipase
8.4.3. Carbohydrates
8.4.4. Nuclease & Polymerase
8.4.5. Others
8.5. Market Analysis, Insights and Forecast - By Country/Sub Region
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. Southeast Asia
8.5.6. Rest of Asia Pacific
9. Latin America Enzymes Market Analysis, Insights and Forecast, 2016-2027
9.1. Key Findings / Summary
9.2. Market Analysis, Insights and Forecast - By Type
9.2.1. Industrial Enzymes
9.2.2. Specialty Enzymes
9.3. Market Analysis, Insights and Forecast - By Source
9.3.1. Plants
9.3.2. Animals
9.3.3. Microorganisms
9.4. Market Analysis, Insights and Forecast – By Product Type
9.4.1. Protease
9.4.2. Lipase
9.4.3. Carbohydrates
9.4.4. Nuclease & Polymerase
9.4.5. Others
9.5. Market Analysis, Insights and Forecast - By Country/Sub Region
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East & Africa Enzymes Market Analysis, Insights and Forecast, 2016-2027
10.1. Key Findings / Summary
10.2. Market Analysis, Insights and Forecast - By Type
10.2.1. Industrial Enzymes
10.2.2. Specialty Enzymes
10.3. Market Analysis, Insights and Forecast - By Source
10.3.1. Plants
10.3.2. Animals
10.3.3. Microorganisms
10.4. Market Analysis, Insights and Forecast – By Product Type
10.4.1. Protease
10.4.2. Lipase
10.4.3. Carbohydrates
10.4.4. Nuclease & Polymerase
10.4.5. Others
10.5. Market Analysis, Insights and Forecast - By Country/Sub Region
10.5.1. GCC Countries
10.5.2. Africa
10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Market Share Analysis (2019)
11.3. Company Profiles (Overview, Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
11.3.1. BASF SE
11.3.1.1. Overview,
11.3.1.2. Services,
11.3.1.3. SWOT analysis,
11.3.1.4. Recent developments,
11.3.1.5. strategies,
11.3.1.6. financials (based on availability)
11.3.2. DuPont
11.3.2.1. Overview,
11.3.2.2. Services,
11.3.2.3. SWOT analysis,
11.3.2.4. Recent developments,
11.3.2.5. strategies,
11.3.2.6. financials (based on availability)
11.3.3. DSM
11.3.3.1. Overview,
11.3.3.2. Services,
11.3.3.3. SWOT analysis,
11.3.3.4. Recent developments,
11.3.3.5. strategies,
11.3.3.6. financials (based on availability)
11.3.4. Novozyme
11.3.4.1. Overview,
11.3.4.2. Services,
11.3.4.3. SWOT analysis,
11.3.4.4. Recent developments,
11.3.4.5. strategies,
11.3.4.6. financials (based on availability)
11.3.5. Roche Holding
11.3.5.1. Overview,
11.3.5.2. Services,
11.3.5.3. SWOT analysis,
11.3.5.4. Recent developments,
11.3.5.5. strategies,
11.3.5.6. financials (based on availability)
11.3.6. Codeix
11.3.6.1. Overview,
11.3.6.2. Services,
11.3.6.3. SWOT analysis,
11.3.6.4. Recent developments,
11.3.6.5. strategies,
11.3.6.6. financials (based on availability)
11.3.7. Sanofi
11.3.7.1. Overview,
11.3.7.2. Services,
11.3.7.3. SWOT analysis,
11.3.7.4. Recent developments,
11.3.7.5. strategies,
11.3.7.6. financials (based on availability)
11.3.8. Advanced Enzymes
11.3.8.1. Overview,
11.3.8.2. Services,
11.3.8.3. SWOT analysis,
11.3.8.4. Recent developments,
11.3.8.5. strategies,
11.3.8.6. financials (based on availability)
11.3.9. Others
11.3.9.1. Overview,
11.3.9.2. Services,
11.3.9.3. SWOT analysis,
11.3.9.4. Recent developments,
11.3.9.5. strategies,
11.3.9.6. financials (based on availability)
12. Strategic Recommendations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings